Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

31 December 2025

Proteogenomic discovery of RB1-defective phenocopy in cancer predicts disease outcome, response to treatment, and therapeutic targets.

28 March 2025

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

17 March 2025

PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

17 March 2025

PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

17 March 2025

High resolution profiling of cell cycle-dependent protein and phosphorylation abundance changes in non-transformed cells.

16 March 2025

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

13 March 2025

CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

04 March 2025

CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

04 March 2025

PBRM1 directs PBAF to pericentromeres and protects centromere integrity.

26 February 2025

PBRM1 directs PBAF to pericentromeres and protects centromere integrity.

26 February 2025

Detection of human unannotated microproteins by mass spectrometry-based proteomics: a community assessment.

26 February 2025